标普和纳斯达克内在价值 联系我们

Opthea Limited OPT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • AU • USD

SharesGrow Score
19/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
-41.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Opthea Limited (OPT) , 前瞻盈利收益率 0.88%.

本页证实的标准:

  • VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($2.00, 41.3%).
  • 前瞻市盈率 113.7
  • 分析师共识目标价 $2.00 (-41.3% 下行风险) — 分析师认为当前价格水平存在明显下行风险。

SharesGrow 综合评分: 19/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
19/100
SG Score
View full scorecard →
价值
10/100
Price-to-Earnings & upside
Proven by this page
未來
37/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
~
护城河
62/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — OPT

估值倍数
P/E (TTM)0.0
前瞻 P/E113.7
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率13,609.70
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
前瞻 EPS(预估)$0.03
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield0.88%
股息收益率0.00%
分析师目标价$2.00 (-41.3%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-0.30 $0.00 $-6.51M -
2017 $-0.27 $0.00 $-6.19M -
2018 $-0.58 $0.00 $-16.9M -
2019 $-0.72 $112.5K $-20.91M -18587.2%
2020 $-0.49 $145.9K $-16.12M -11047%
2021 $-1.44 $91.98K $-60.79M -66087.6%
2022 $-2.72 $125.05K $-127.99M -102353.7%
2023 $-3.60 $161.16K $-211.88M -131469.8%
2024 $-22.16 $124.67K $-220.24M -176665.7%
2025 $0.00 $38.36K $-250M -651771.5%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言